April 18, 2014 — A University of California, San Diego scientist has developed a new biomaterial that could potentially treat heart attacks. Karen Christman, Ph.D., associate professor of bioengineering at UC San Diego Jacobs School of Engineering, has been at work on a new injectable hydrogel, which is designed to repair damaged cardiac tissue following a heart attack.


April 18, 2014 — AliveCor announced the online publication of study results of the SEARCH-AF study. The SEARCH-AF study, conducted in Australia, screened 1,000 customers over 65 years old for atrial fibrillation (AF) in 10 community pharmacies in suburban Sydney.

Medtronic announced the U.S. Food and Drug Administration (FDA) approved an expanded indication for biventricular (BiV) pacing with Medtronic cardiac resynchronization therapy-pacemakers and -defibrillators (CRT-P and CRT-D). Medtronic CRT devices are now approved to treat patients with atrioventricular (AV) block and left ventricular (LV) systolic dysfunction, reducing heart failure hospitalizations and mortality, and improving cardiac function in these patients.

Toshiba America Medical Systems Inc. received approval to operate (ATO) with the U.S. Air Force, making Toshiba the only current manufacturer to have a fully certified computed tomography (CT) system for use on the Air Force Network.

Data presented from two meta-analyses using the Atherotech Vertical Auto Profile (VAP) lipid panel showed the impact high-density lipoprotein (HDL) cholesterol and remnant lipoprotein (RLP) cholesterol have on determining a patient’s risk for hard coronary heart disease (CHD) endpoints, such as myocardial infarction or coronary death.

ACC 14 Clinical Trial Women Diet Drinks Cardiovascular Problem Mortality

Healthy postmenopausal women who drink two or more diet drinks a day may be more likely to have a heart attack, stroke or other cardiovascular problems, according to research to be presented at the American College of Cardiology’s 63rd Annual Scientific Session.

April 16, 2014 — Covidien announced it has notified customers of a voluntary recall to address an issue with certain lots of its Pipeline embolization device and Alligator retrieval device, where the polytetrafluoroethylene (PTFE) coating applied to the delivery wire could delaminate and detach from the devices.


April 16, 2014 — Abbott announced it has completed enrollment of three clinical trials to support approvals of the company's Absorb bioresorbable vascular scaffold (BVS) in the United States, Japan and China. Combined, the U.S., Japan and China account for more than 50 percent of the world's heart stent market. Absorb received CE mark in 2011 and is available in more than 60 countries around the world.
Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now